SLBT · NASDAQ · Biotechnology

SL Science (SLBT)

Develops licensed immune-cell therapies alongside Taiwan exosome and hair-care products.

$1.79
After-hours close+0.11 (+6.52%)
At close$1.68(−2.33%)

Not reported.